Kimberly-Clark said on Nov. 3 that it will purchase Tylenol and Band-Aid parent company Kenvue in a $48.7 billion deal, forming an enormous consumer staples conglomerate.
The cash-and-stock deal includes Huggies-maker Kimberly-Clark paying $21.01 for each Kenvue share—a 41 percent premium from its Oct. 31 closing price. The acquisition, one of the largest on Wall Street this year, is expected to close in the second half of 2026.
